1	Gingival	Gingival	B-NP	NN	O	2	NMOD
2	changes	change	I-NP	NNS	O	0	ROOT
3	during	during	B-PP	IN	O	2	NMOD
4	pregnancy	pregnancy	B-NP	NN	O	3	PMOD
5	:	:	O	:	O	2	P
6	III	III	B-NP	CD	O	2	NMOD
7	.	.	O	.	O	2	P

1	Impact	Impact	B-NP	NN	O	0	ROOT
2	of	of	B-PP	IN	O	1	NMOD
3	clinical	clinical	B-NP	JJ	O	10	NMOD
4	,	,	I-NP	,	O	10	P
5	microbiological	microbiological	I-NP	JJ	O	10	NMOD
6	,	,	I-NP	,	O	10	P
7	immunological	immunological	I-NP	JJ	O	10	NMOD
8	and	and	I-NP	CC	O	10	NMOD
9	socio-demographic	socio-demographic	I-NP	JJ	B-protein	10	NMOD
10	factors	factor	I-NP	NNS	I-protein	2	PMOD
11	on	on	B-PP	IN	O	1	NMOD
12	gingival	gingival	B-NP	JJ	O	13	NMOD
13	inflammation	inflammation	I-NP	NN	O	11	PMOD
14	.	.	O	.	O	1	P

1	To	To	B-VP	TO	O	2	VMOD
2	identify	identify	I-VP	VB	O	0	ROOT
3	predictor	predictor	B-NP	NN	O	4	NMOD
4	variables	variable	I-NP	NNS	O	2	OBJ
5	involved	involve	B-VP	VBN	O	4	NMOD
6	in	in	B-PP	IN	O	5	VMOD
7	exacerbated	exacerbated	B-NP	JJ	O	9	NMOD
8	gingival	gingival	I-NP	JJ	O	9	NMOD
9	inflammation	inflammation	I-NP	NN	O	6	PMOD
10	associated	associate	B-VP	VBN	O	9	NMOD
11	with	with	B-PP	IN	O	10	VMOD
12	pregnancy	pregnancy	B-NP	NN	O	11	PMOD
13	.	.	O	.	O	2	P

1	In	In	B-PP	IN	O	14	VMOD
2	this	this	B-NP	DT	O	4	NMOD
3	cohort	cohort	I-NP	JJ	O	4	NMOD
4	study	study	I-NP	NN	O	1	PMOD
5	,	,	O	,	O	14	P
6	48	48	B-NP	CD	O	11	NMOD
7	pregnant	pregnant	I-NP	JJ	O	6	NMOD
8	and	and	O	CC	O	11	NMOD
9	28	28	B-NP	CD	O	11	NMOD
10	non-pregnant	non-pregnant	I-NP	JJ	O	11	NMOD
11	women	woman	I-NP	NNS	O	14	SUB
12	without	without	B-PP	IN	O	11	NMOD
13	periodontitis	periodontitis	B-NP	NN	O	12	PMOD
14	were	be	B-VP	VBD	O	0	ROOT
15	included	include	I-VP	VBN	O	14	VC
16	.	.	O	.	O	14	P

1	The	The	B-NP	DT	O	3	NMOD
2	pregnant	pregnant	I-NP	JJ	O	3	NMOD
3	women	woman	I-NP	NNS	O	4	SUB
4	were	be	B-VP	VBD	O	0	ROOT
5	evaluated	evaluate	I-VP	VBN	O	4	VC
6	in	in	B-PP	IN	O	5	VMOD
7	the	the	B-NP	DT	O	13	NMOD
8	first	first	I-NP	JJ	O	12	AMOD
9	,	,	I-NP	,	O	12	P
10	second	second	I-NP	JJ	O	12	AMOD
11	and	and	I-NP	CC	O	12	AMOD
12	third	third	I-NP	JJ	O	13	NMOD
13	trimester	trimester	I-NP	NN	O	6	PMOD
14	and	and	B-PP	CC	O	6	PMOD
15	at	at	B-PP	IN	O	6	PMOD
16	3	3	B-NP	CD	O	17	NMOD
17	months	month	I-NP	NNS	O	15	PMOD
18	postpartum	postpartum	B-NP	NN	O	15	PMOD
19	,	,	O	,	O	5	P
20	whilst	whilst	B-PP	IN	O	5	VMOD
21	the	the	B-NP	DT	O	23	NMOD
22	non-pregnant	non-pregnant	I-NP	JJ	O	23	NMOD
23	women	woman	I-NP	NNS	O	24	SUB
24	were	be	B-VP	VBD	O	20	SBAR
25	evaluated	evaluate	I-VP	VBN	O	24	VC
26	twice	twice	B-ADVP	RB	O	25	VMOD
27	,	,	O	,	O	25	P
28	with	with	B-PP	IN	O	25	VMOD
29	a	a	B-NP	DT	O	31	NMOD
30	6-month	6-month	I-NP	JJ	O	31	NMOD
31	interval	interval	I-NP	NN	O	28	PMOD
32	.	.	O	.	O	4	P

1	At	At	B-PP	IN	O	57	VMOD
2	each	each	B-NP	DT	O	3	NMOD
3	visit	visit	I-NP	NN	O	1	PMOD
4	,	,	O	,	O	57	P
5	clinical	clinical	B-NP	JJ	O	39	NMOD
6	[	[	I-NP	(	O	18	DEP
7	plaque	plaque	I-NP	NN	O	8	NMOD
8	index	index	I-NP	NN	O	14	NMOD
9	(	(	O	(	O	11	DEP
10	PlI	PlI	B-NP	NN	B-protein	11	DEP
11	)	)	O	)	O	8	NMOD
12	and	and	O	CC	O	14	NMOD
13	gingival	gingival	B-NP	JJ	O	14	NMOD
14	index	index	I-NP	NN	O	18	DEP
15	(	(	O	(	O	17	DEP
16	GI	GI	B-NP	NN	O	17	DEP
17	)	)	O	)	O	14	NMOD
18	]	]	O	)	O	5	NMOD
19	,	,	O	,	O	39	P
20	hormonal	hormonal	O	JJ	O	39	NMOD
21	(	(	O	(	O	26	DEP
22	salivary	salivary	B-NP	JJ	O	23	NMOD
23	progesterone	progesterone	I-NP	NN	O	25	NMOD
24	and	and	I-NP	CC	O	25	NMOD
25	estradiol	estradiol	I-NP	NN	O	26	DEP
26	)	)	O	)	O	20	NMOD
27	,	,	O	,	O	39	P
28	immunological	immunological	B-NP	JJ	B-protein	33	NMOD
29	[	[	I-NP	(	I-protein	33	NMOD
30	gingival	gingival	I-NP	JJ	I-protein	33	NMOD
31	crevicular	crevicular	I-NP	JJ	I-protein	33	NMOD
32	fluid	fluid	I-NP	NN	I-protein	33	NMOD
33	interleukin-1β	interleukin-1β	I-NP	NN	I-protein	39	NMOD
34	,	,	O	,	O	39	P
35	interleukin-6	interleukin-6	B-NP	NN	B-protein	39	NMOD
36	,	,	O	,	O	39	P
37	tumour	tumour	B-NP	NN	O	39	NMOD
38	necrosis	necrosis	I-NP	NN	O	39	NMOD
39	factor-α	factor-α	I-NP	NN	O	44	NMOD
40	(	(	O	(	O	42	DEP
41	TNF-α	TNF-α	B-NP	NN	O	42	DEP
42	)	)	O	)	O	39	NMOD
43	and	and	O	CC	O	44	NMOD
44	prostaglandin-E	prostaglandin-E	B-NP	NN	O	56	NMOD
45	(	(	O	(	O	47	DEP
46	2	2	B-NP	CD	O	47	DEP
47	)	)	O	)	O	44	NMOD
48	]	]	O	)	O	44	NMOD
49	and	and	O	CC	O	56	NMOD
50	microbiological	microbiological	O	JJ	O	56	NMOD
51	(	(	O	(	O	55	DEP
52	periodontal	periodontal	B-NP	JJ	O	54	NMOD
53	pathogens	pathogen	I-NP	NNS	O	54	NMOD
54	culture	culture	I-NP	NN	O	55	DEP
55	)	)	O	)	O	50	AMOD
56	evaluations	evaluation	B-NP	NNS	O	57	SUB
57	were	be	B-VP	VBD	O	0	ROOT
58	performed	perform	I-VP	VBN	O	57	VC
59	.	.	O	.	O	57	P

1	Statistical	Statistical	B-NP	JJ	O	2	NMOD
2	analysis	analysis	I-NP	NN	O	3	SUB
3	was	be	B-VP	VBD	O	0	ROOT
4	undertaken	undertake	I-VP	VBN	O	3	VC
5	using	use	B-VP	VBG	O	3	VMOD
6	exhaustive	exhaustive	B-NP	JJ	O	10	NMOD
7	chi-square	chi-square	I-NP	JJ	O	10	NMOD
8	automatic	automatic	I-NP	JJ	O	10	NMOD
9	interaction	interaction	I-NP	NN	O	10	NMOD
10	detection	detection	I-NP	NN	O	5	OBJ
11	(	(	O	(	O	14	DEP
12	exhaustive	exhaustive	B-NP	JJ	O	13	NMOD
13	CHAID	CHAID	I-NP	NN	O	14	DEP
14	)	)	O	)	O	10	NMOD
15	to	to	B-VP	TO	O	16	VMOD
16	analyse	analyse	I-VP	VB	O	5	VMOD
17	the	the	B-NP	DT	O	19	NMOD
18	predictive	predictive	I-NP	JJ	O	19	NMOD
19	value	value	I-NP	NN	O	16	OBJ
20	of	of	B-PP	IN	O	19	NMOD
21	the	the	B-NP	DT	O	23	NMOD
22	independent	independent	I-NP	JJ	O	23	NMOD
23	outcomes	outcome	I-NP	NNS	O	20	PMOD
24	to	to	B-VP	TO	O	25	VMOD
25	develop	develop	I-VP	VB	O	5	VMOD
26	pregnancy	pregnancy	B-NP	NN	O	27	NMOD
27	GI	GI	I-NP	NN	O	25	OBJ
28	.	.	O	.	O	3	P

1	PlI	PlI	B-NP	NN	B-protein	2	SUB
2	was	be	B-VP	VBD	O	0	ROOT
3	the	the	B-NP	DT	O	5	NMOD
4	strongest	strong	I-NP	JJS	O	5	NMOD
5	predictor	predictor	I-NP	NN	O	2	PRD
6	implicated	implicate	B-VP	VBN	O	5	NMOD
7	in	in	B-PP	IN	O	6	VMOD
8	the	the	B-NP	DT	O	9	NMOD
9	GI	GI	I-NP	NN	O	7	PMOD
10	throughout	throughout	B-PP	IN	O	6	VMOD
11	pregnancy	pregnancy	B-NP	NN	O	10	PMOD
12	and	and	B-PP	CC	O	10	PMOD
13	after	after	B-PP	IN	O	10	PMOD
14	delivery	delivery	B-NP	NN	O	10	PMOD
15	.	.	O	.	O	2	P

1	During	During	B-PP	IN	O	0	ROOT
2	the	the	B-NP	DT	O	6	NMOD
3	second	second	I-NP	JJ	O	5	AMOD
4	and	and	I-NP	CC	O	5	AMOD
5	third	third	I-NP	JJ	O	6	NMOD
6	trimesters	trimester	I-NP	NNS	O	1	PMOD
7	the	the	B-NP	DT	O	8	NMOD
8	presence	presence	I-NP	NN	O	1	VMOD
9	of	of	B-PP	IN	O	8	NMOD
10	Porphyromonas	Porphyromonas	B-NP	NN	O	11	NMOD
11	gingivalis	gingivalis	I-NP	NN	O	9	PMOD
12	significantly	significantly	B-ADVP	RB	O	13	VMOD
13	contributed	contribute	B-VP	VBD	O	8	NMOD
14	to	to	B-PP	TO	O	13	VMOD
15	the	the	B-NP	DT	O	16	NMOD
16	worsening	worsening	I-NP	NN	O	14	PMOD
17	of	of	B-PP	IN	O	16	NMOD
18	gingival	gingival	B-NP	JJ	O	19	NMOD
19	inflammation	inflammation	I-NP	NN	O	17	PMOD
20	.	.	O	.	O	1	P

1	When	When	B-ADVP	WRB	O	10	VMOD
2	compared	compare	B-PP	VBN	O	1	SBAR
3	with	with	B-PP	IN	O	2	VMOD
4	the	the	B-NP	DT	O	6	NMOD
5	non-pregnant	non-pregnant	I-NP	JJ	O	6	NMOD
6	group	group	I-NP	NN	O	3	PMOD
7	,	,	O	,	O	10	P
8	significant	significant	B-NP	JJ	O	9	NMOD
9	differences	difference	I-NP	NNS	O	10	SUB
10	were	be	B-VP	VBD	O	0	ROOT
11	found	find	I-VP	VBN	O	10	VC
12	in	in	B-PP	IN	O	11	VMOD
13	TNF-α	TNF-α	B-NP	NN	O	14	NMOD
14	amounts	amount	I-NP	NNS	O	16	NMOD
15	and	and	I-NP	CC	O	16	NMOD
16	concentrations	concentration	I-NP	NNS	O	12	PMOD
17	and	and	O	CC	O	12	PMOD
18	in	in	B-PP	IN	O	12	PMOD
19	the	the	B-NP	DT	O	23	NMOD
20	third	third	I-NP	JJ	O	23	NMOD
21	trimester	trimester	I-NP	NN	O	23	NMOD
22	site-specific	site-specific	I-NP	JJ	O	23	NMOD
23	GI	GI	I-NP	NN	O	18	PMOD
24	.	.	O	.	O	10	P

1	Bacterial	Bacterial	B-NP	JJ	O	2	NMOD
2	challenge	challenge	I-NP	NN	O	20	SUB
3	to	to	B-PP	TO	O	2	NMOD
4	the	the	B-NP	DT	O	6	NMOD
5	gingival	gingival	I-NP	JJ	O	6	NMOD
6	tissues	tissue	I-NP	NNS	O	3	PMOD
7	,	,	O	,	O	20	P
8	both	both	O	CC	O	20	VMOD
9	quantitatively	quantitatively	O	RB	O	20	VMOD
10	(	(	O	(	O	12	DEP
11	PlI	PlI	B-NP	NN	B-protein	12	DEP
12	)	)	O	)	O	9	AMOD
13	and	and	O	CC	O	20	VMOD
14	qualitatively	qualitatively	B-ADVP	RB	O	20	SUB
15	(	(	O	(	O	19	DEP
16	harbouring	harbour	B-VP	VBG	O	19	DEP
17	P.	P.	B-NP	NNP	O	18	NMOD
18	gingivalis	gingivalis	I-NP	NNP	O	16	OBJ
19	)	)	O	)	O	14	AMOD
20	appears	appear	B-VP	VBZ	O	0	ROOT
21	to	to	I-VP	TO	O	22	VMOD
22	affect	affect	I-VP	VB	O	20	VMOD
23	the	the	B-NP	DT	O	24	NMOD
24	level	level	I-NP	NN	O	22	OBJ
25	of	of	B-PP	IN	O	24	NMOD
26	gingival	gingival	B-NP	JJ	O	27	NMOD
27	inflammation	inflammation	I-NP	NN	O	25	PMOD
28	observed	observe	B-VP	VBN	O	24	NMOD
29	during	during	B-PP	IN	O	28	VMOD
30	pregnancy	pregnancy	B-NP	NN	O	29	PMOD
31	.	.	O	.	O	20	P

